{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:29:18Z","timestamp":1763555358445,"version":"3.45.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["C-23K08862"],"award-info":[{"award-number":["C-23K08862"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24481-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:24:53Z","timestamp":1763555093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic and prognostic values of circulating growth differentiation factor-15 and osteopontin in uterine sarcoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Hideaki","family":"Tsuyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoyasu","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Orisaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"6","key":"24481_CR1","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/cas.13613","volume":"109","author":"H Tsuyoshi","year":"2018","unstructured":"Tsuyoshi, H. & Yoshida, Y. Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcoma. Cancer Sci. 109(6), 1743\u20131752 (2018).","journal-title":"Cancer Sci."},{"issue":"3","key":"24481_CR2","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijgo.2008.12.008","volume":"104","author":"J Prat","year":"2009","unstructured":"Prat, J. FIGO staging for uterine sarcomas. Int. J. Gynaecol. Obstet. 104(3), 177\u2013178 (2009).","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"4","key":"24481_CR3","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.fertnstert.2008.08.074","volume":"92","author":"C Templeman","year":"2009","unstructured":"Templeman, C. et al. Risk factors for surgically removed fibroids in a large cohort of teachers. Fertil. Steril. 92(4), 1436\u20131446 (2009).","journal-title":"Fertil. Steril."},{"issue":"3","key":"24481_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00404-015-3664-7","volume":"292","author":"F Ebner","year":"2015","unstructured":"Ebner, F. et al. Is open surgery the solution to avoid morcellation of uterine sarcomas? A systematic literature review on the effect of tumor morcellation and surgical techniques. Arch Gynecol. Obstet. 292(3), 499\u2013506 (2015).","journal-title":"Arch Gynecol. Obstet."},{"issue":"11","key":"24481_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1111\/jog.13436","volume":"43","author":"H Tsuyoshi","year":"2017","unstructured":"Tsuyoshi, H. & Yoshida, Y. Diagnostic imaging using positron emission tomography for gynecological malignancy. J. Obstet. Gynaecol. Res. 43(11), 1687\u20131699 (2017).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"24481_CR6","doi-asserted-by":"publisher","first-page":"1215194","DOI":"10.3389\/fonc.2023.1215194","volume":"13","author":"A Rezaee","year":"2023","unstructured":"Rezaee, A. et al. MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: Focus on metastasis. Front. Oncol. 13, 1215194 (2023).","journal-title":"Front. Oncol."},{"issue":"8","key":"24481_CR7","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.21873\/anticanres.13553","volume":"39","author":"N Glorie","year":"2019","unstructured":"Glorie, N., Baert, T., DEN Bosch, V. A. N. & T, Coosemans AN,. Circulating protein biomarkers to differentiate uterine sarcomas from leiomyomas. Anticancer. Res. 39(8), 3981\u20133989 (2019).","journal-title":"Anticancer. Res."},{"issue":"1","key":"24481_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1507\/endocrj.EJ18-0572","volume":"67","author":"M Maeno","year":"2020","unstructured":"Maeno, M. et al. Development of a novel and rapid measurement system for growth differentiation factor-15, progranulin, and osteopontin in uterine sarcoma. Endocr. J. 67(1), 91\u201394 (2020).","journal-title":"Endocr. J."},{"issue":"10","key":"24481_CR9","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1007\/s00259-011-1851-8","volume":"38","author":"Y Yoshida","year":"2011","unstructured":"Yoshida, Y. et al. Additional value of 16\u03b1-[18F]fluoro-17\u03b2-oestradiol PET for differential diagnosis between uterine sarcoma and leiomyoma in patients with positive or equivocal findings on [18F]fluorodeoxyglucose PET. Eur. J. Nucl. Med. Mol. Imaging. 38(10), 1824\u20131831 (2011).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging."},{"issue":"18","key":"24481_CR10","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1016\/j.ejca.2010.09.004","volume":"46","author":"Y Yoshida","year":"2010","unstructured":"Yoshida, Y. et al. Localisation of phosphorylated mTOR expression is critical to tumour progression and outcomes in patients with endometrial cancer. Eur. J. Cancer. 46(18), 3445\u20133452 (2010).","journal-title":"Eur. J. Cancer."},{"issue":"1","key":"24481_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12885-020-06965-4","volume":"20","author":"H Tsuyoshi","year":"2020","unstructured":"Tsuyoshi, H. et al. Prognostic impact of Dynamin related protein 1 (Drp1) in epithelial ovarian cancer. BMC Cancer 20(1), 467 (2020).","journal-title":"BMC Cancer"},{"issue":"1","key":"24481_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/jog.13792","volume":"45","author":"Y Nishigaya","year":"2019","unstructured":"Nishigaya, Y. et al. Diagnostic value of combination serum assay of lactate dehydrogenase, D-dimer, and C-reactive protein for uterine leiomyosarcoma. J. Obstet. Gynaecol. Res. 45(1), 189\u2013194 (2019).","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"2","key":"24481_CR13","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.211658","volume":"306","author":"N Hindman","year":"2023","unstructured":"Hindman, N. et al. MRI evaluation of uterine masses for risk of leiomyosarcoma: A consensus statement. Radiology 306(2), e211658 (2023).","journal-title":"Radiology"},{"issue":"5","key":"24481_CR14","doi-asserted-by":"publisher","first-page":"708","DOI":"10.2967\/jnumed.107.047142","volume":"49","author":"Y Yoshida","year":"2008","unstructured":"Yoshida, Y. et al. Comparison of 18F-FDG PET and MRI in assessment of uterine smooth muscle tumors. J. Nucl. Med. 49(5), 708\u2013712 (2008).","journal-title":"J. Nucl. Med."},{"issue":"7","key":"24481_CR15","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1097\/RLU.0000000000004258","volume":"47","author":"T Tsujikawa","year":"2022","unstructured":"Tsujikawa, T. et al. PET imaging of estrogen receptors for gynecological tumors. Clin. Nucl. Med. 47(7), e481\u2013e488 (2022).","journal-title":"Clin. Nucl. Med."},{"issue":"3","key":"24481_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ygyno.2010.05.032","volume":"118","author":"AC Staff","year":"2010","unstructured":"Staff, A. C. et al. Growth differentiation factor-15 as a prognostic biomarker in ovarian cancer. Gynecol. Oncol. 118(3), 237\u2013243 (2010).","journal-title":"Gynecol. Oncol."},{"issue":"14","key":"24481_CR17","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1158\/1078-0432.CCR-11-0715","volume":"17","author":"AC Staff","year":"2011","unstructured":"Staff, A. C. et al. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer. Clin. Cancer Res. 17(14), 4825\u20134833 (2011).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"24481_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210585","volume":"14","author":"H Engerud","year":"2019","unstructured":"Engerud, H. et al. Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer. PLoS ONE 14(1), e0210585 (2019).","journal-title":"PLoS ONE"},{"issue":"1","key":"24481_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ygyno.2010.09.006","volume":"120","author":"JJ Han","year":"2011","unstructured":"Han, J. J., Yu, M., Houston, N., Steinberg, S. M. & Kohn, E. C. Progranulin is a potential prognostic biomarker in advanced epithelial ovarian cancers. Gynecol. Oncol. 120(1), 5\u201310 (2011).","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"24481_CR20","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/jog.12097","volume":"39","author":"R Moszynski","year":"2013","unstructured":"Moszynski, R., Szubert, S., Szpurek, D., Michalak, S. & Sajdak, S. Role of osteopontin in differential diagnosis of ovarian tumors. J. Obstet. Gynaecol. Res. 39(11), 1518\u20131525 (2013).","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"24481_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2020.103893","volume":"226","author":"A Periyasamy","year":"2020","unstructured":"Periyasamy, A., Gopisetty, G., Subramanium, M. J., Velusamy, S. & Rajkumar, T. Identification and validation of differential plasma proteins levels in epithelial ovarian cancer. J. Proteom. 226, 103893 (2020).","journal-title":"J. Proteom."},{"issue":"2","key":"24481_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1097\/IGC.0000000000000037","volume":"24","author":"J Trovik","year":"2014","unstructured":"Trovik, J., Salvesen, H. B., Cuppens, T., Amant, F. & Staff, A. C. Growth differentiation factor-15 as biomarker in uterine sarcomas. Int. J. Gynecol. Cancer. 24(2), 252\u2013259 (2014).","journal-title":"Int. J. Gynecol. Cancer."},{"key":"24481_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2022.101569","volume":"75","author":"M Conte","year":"2022","unstructured":"Conte, M. et al. GDF15, an emerging key player in human aging. Ageing Res. Rev. 75, 101569 (2022).","journal-title":"Ageing Res. Rev."},{"key":"24481_CR24","doi-asserted-by":"publisher","first-page":"1014853","DOI":"10.3389\/fendo.2022.1014853","volume":"13","author":"Y Du","year":"2022","unstructured":"Du, Y. et al. Osteopontin\u2014The stirring multifunctional regulatory factor in multisystem aging. Front. Endocrinol. (Lausanne). 13, 1014853 (2022).","journal-title":"Front. Endocrinol. (Lausanne)."},{"issue":"4","key":"24481_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1068-607X(98)00046-8","volume":"5","author":"HN Nguyen","year":"1998","unstructured":"Nguyen, H. N., Jacobson, A. & Patino-Paul, R. New reference levels for CA125 in pre- and postmenopausal women. Prim. Care Update Ob. Gyns. 5(4), 157 (1998).","journal-title":"Prim. Care Update Ob. Gyns."},{"issue":"5","key":"24481_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3390\/cancers16050938","volume":"16","author":"RA Denu","year":"2024","unstructured":"Denu, R. A., Dann, A. M., Keung, E. Z., Nakazawa, M. S. & Nassif Haddad, E. F. The future of targeted therapy for leiomyosarcoma. Cancers (Basel). 16(5), 938 (2024).","journal-title":"Cancers (Basel)."},{"key":"24481_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ygyno.2023.02.009","volume":"171","author":"A Gadducci","year":"2023","unstructured":"Gadducci, A. et al. Endometrial stromal tumors of the uterus: Epidemiology, pathological and biological features, treatment options and clinical outcomes. Gynecol. Oncol. 171, 95\u2013105 (2023).","journal-title":"Gynecol. Oncol."},{"issue":"5","key":"24481_CR28","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1158\/1078-0432.CCR-05-2003","volume":"12","author":"N Matsumura","year":"2006","unstructured":"Matsumura, N. et al. Oncogenic property of acrogranin in human uterine leiomyosarcoma: Direct evidence of genetic contribution in in vivo tumorigenesis. Clin. Cancer Res. 12(5), 1402\u20131411 (2006).","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"24481_CR29","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.3390\/ijms24032925","volume":"24","author":"M Joo","year":"2023","unstructured":"Joo, M., Kim, D., Lee, M. W., Lee, H. J. & Kim, J. M. GDF15 promotes cell growth, migration, and invasion in gastric cancer by inducing STAT3 activation. Int. J. Mol. Sci. 24(3), 2925 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"24481_CR30","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/bjc.2011.112","volume":"104","author":"U Wallin","year":"2011","unstructured":"Wallin, U. et al. Growth differentiation factor 15: A prognostic marker for recurrence in colorectal cancer. Br. J. Cancer. 104(10), 1619\u20131627 (2011).","journal-title":"Br. J. Cancer."},{"key":"24481_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen, J., Melero, I. & Fridman, W. H. Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front. Immunol. 11, 951 (2020).","journal-title":"Front. Immunol."},{"issue":"12","key":"24481_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.humimm.2021.06.007","volume":"82","author":"RS Lodi","year":"2021","unstructured":"Lodi, R. S., Yu, B., Xia, L. & Liu, F. Roles and regulation of growth differentiation factor-15 in the Immune and tumor microenvironment. Hum. Immunol. 82(12), 937\u2013944 (2021).","journal-title":"Hum. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24481-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24481-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:24:54Z","timestamp":1763555094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24481-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24481"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24481-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study protocol was approved by the Institutional Review Board of the University of Fukui Hospital (IRB Number: 20150028). First, it was a retrospective study. The patients provided written informed consent to participate in the study and anonymous clinical data were used. Patients provided written consent for the use of residual samples and were offered an opt-out option as disclosed on the website (\n                      \n                      and Registration No is N\/A. Animal Studies is N\/A. All methods were performed in accordance with approved guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"40839"}}